Pharma Deals Review, Vol 2005, No 57 (2005)

Font Size:  Small  Medium  Large

Chiesi Licenses Second Drug to GB Therapeutics

Business Review Editor

Abstract


Chiesi Farmaceutici exclusively licensed its CHF1512/GT1512 drug to GB Therapeutics. The drug is a combination of melevodopa hydrochloride and carbidopa for the treatment of Parkinson’s disease.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.